From Sep. 13th-5th, 2023, the Medical Fair Thailand 2023 was successfully held at the Bangkok International Trade and Exhibition Centre in Thailand. Over 12,000 medical professionals from more than 80 countries and regions gathered to discuss the latest developments in the healthcare industry.

Biotime's multi-platform POCT solutions, including chemiluminescence, immunofluorescence, and colloidal gold, made a remarkable appearance at this grand event. Among Biotime's star products, BIOT-YG-I, FLI-100, FLI-600, and FLI-4000 were prominently featured at the international exhibition. These products were highly praised for their flexible and rapid testing methods, offering a wide range of POCT testing solutions for conditions such as cardiac markers, inflammation, hormones, and thyroid function. Results can be obtained in as little as 3 minutes, effectively meeting the testing needs of various medical institutions.

In addition to these products, Biotime's POCT solutions for COVID-19, monkeypox, diabetes, and more garnered significant attention at the exhibition. Many clients visited the booth to explore these solutions, engage in discussions, and explore potential business collaborations.

In addition to the Medical Fair in Thailand, during nearly the same period, Biotime also made appearances at several other significant healthcare industry exhibitions. These included the 18th Vietnam International Medical Exhibition (PHARMEDI VIETNAM) and the 8th East Africa Kenya International Medical Equipment Exhibition (Medic East Africa). These events provided valuable platforms for Biotime to engage with international colleagues, exchange insights on new products, technologies, and solutions, foster discussions on collaboration, and collectively chart a path for further development in the healthcare sector.

With over a decade of dedicated experience in the IVD field, Biotime Biotechnology has established a strong foothold. We have expertise spanning multiple technological platforms, including chemiluminescence, molecular diagnostics, chromatography, mass spectrometry, dry chemistry, electrochemistry, fluorescence immunoassay, and colloidal gold. Our extensive portfolio comprises more than 50 testing items, catering to diverse usage scenarios.

Looking ahead, while maintaining a strong presence in the domestic market, Biotime is committed to expanding its footprint in international markets. We are poised to contribute our expertise to the global biopharmaceutical industry's advancement and growth